|
 In order to address major aesthetic medicine concerns like localised fat reduction, improvement in the appearance of cellulite and skin tightening across the face and body, renowned cosmetic dermatologist Dr Rashmi Shetty has launched ONDA PRO - an advanced non-invasive aesthetic platform developed by DEKA International, Italy, in Mumbai. The platform is powered by DEKA’s patented Coolwaves microwave technology.
The Mumbai introduction of ONDA PRO reflects this changing environment, bringing an Italian-developed technology to Indian aesthetic practice through a physician-led introduction.
The launch featured a live patient demonstration. The event was attended by Francesco Badii, head of DEKA International, Italy; Somen Banerjee, CMD, GeoMedics Pharma Pvt. Ltd; Neehar Gandhi, director – sales & marketing, GeoMedics Pharma Pvt. Ltd along with practicing dermatologists and other stakeholders from the aesthetic medicine community.
With the rapid expansion of the aesthetic device market, physicians and patients are increasingly exposed to terms such as “advanced technology,” “next-generation,” “non-invasive” and “clinically proven.” But behind the marketing language, the underlying engineering and research can vary considerably.
For Dr Rashmi Shetty, technology adoption in aesthetic medicine must begin with a much more fundamental question: does the technology have a sound scientific rationale, and does it offer a meaningful advantage in clinical practice?
Speaking at the launch, Dr Rashmi Shetty, renowned cosmetic dermatologist, international speaker and author with over 20 years of experience, said “Aesthetic dermatology is moving decisively towards technologies that deliver measurable outcomes without significant downtime, because that is what patients increasingly expect. But for me, the important question is always what lies behind the technology — the science, the precision of energy delivery and the research that has gone into developing it.” Dr Rashmi Shetty added “What interests me clinically about Coolwaves is the depth and selectivity of energy delivery. It gives us the ability to address adipose tissue and tissue tightening within the same technology platform, across both face and body. That kind of versatility can be valuable when treatment is planned around the individual patient rather than around the limitations of a particular device.”
Dr. Rashmi Shetty further emphasised that technology should complement, rather than replace, clinical judgement. “My primary responsibility as a doctor is to assess whether a technology is scientifically supported and whether it genuinely contributes to patient care, comfort and safety. A sophisticated device is only meaningful when it is used appropriately, with the right patient selection, protocols and clinical understanding.”
ONDA PRO has been developed by DEKA, an Italian medical technology company with decades of experience in the development of energy-based medical and aesthetic systems.
At the centre of the platform is Coolwaves, DEKA’s patented microwave technology. The technology has been developed to deliver microwave energy selectively to targeted tissue depths, with the aim of addressing adipose tissue while protecting the skin surface through its controlled energy delivery and cooling approach.
The platform is designed for non-invasive applications including localised fat reduction, cellulite improvement and skin tightening, offering physicians a technology platform that can address multiple aesthetic concerns.
Francesco Badii, head of DEKA International, said “DEKA has spent decades developing energy-based medical technologies, and Coolwaves is the result of research into how microwave energy can be applied selectively to adipose tissue while protecting the overlying skin. ONDA PRO carries this technological development forward into a platform designed around the evolving needs of aesthetic medicine.” He added “The global aesthetic market is changing. Patients want effective treatments without surgery and with minimal disruption to their lives, while physicians want technology that is reliable, reproducible and supported by evidence. Our focus at DEKA is to develop technology with a strong engineering and research foundation rather than simply following market trends.”
The introduction of ONDA PRO comes at a time when India's aesthetic medicine market is becoming increasingly sophisticated. Patients are more informed, physicians are exposed to global technologies and expectations around treatment outcomes, safety and downtime are evolving.
This is creating greater interest in technologies where engineering, R&D, treatment precision and clinical application are central to the platform rather than simply the marketing proposition.
Somen Banerjee, CMD, GeoMedics Pharma Pvt. Ltd on the occasion said “India's aesthetic medicine ecosystem is evolving rapidly. Doctors are increasingly looking beyond the device itself and asking about the technology, the science, the training and the support behind it. ONDA PRO represents the kind of advanced technology that we believe can contribute meaningfully to this evolution.” He added “For us, bringing a technology to India is not simply about placing machines. It is about creating the ecosystem around the technology — appropriate physician training, protocols, application support and reliable service. Responsible adoption has to be part of the journey.”
As the Indian market for non-invasive aesthetic procedures expands, access to sophisticated equipment alone is not sufficient. Physician education, hands-on training, treatment protocols and after-sales technical support are increasingly important factors in the successful adoption of advanced platforms.
Neehar Gandhi, director – sales & marketing, GeoMedics Pharma Pvt. Ltd said “The Indian aesthetic market is becoming much more discerning. Doctors today are evaluating technologies based on what is behind them — the engineering, the R&D, the clinical applications, the training and the long-term support. Our responsibility is to ensure that when a technology such as ONDA PRO enters India, physicians receive the right education and support to use it responsibly and effectively.”
The live patient demonstration at Dr. Rashmi Shetty’s clinic provided dermatologists with an opportunity to observe the technology in a clinical setting and understand its potential applications.
|